Literature DB >> 17950798

Usefulness of fasting blood glucose to predict vascular outcomes among individuals without diabetes mellitus (from the Northern Manhattan Study).

Kazuo Eguchi1, Bernadette Boden-Albala, Zhezhen Jin, Marco R Di Tullio, Tatjana Rundek, Carlos J Rodriguez, Shunichi Homma, Ralph L Sacco.   

Abstract

It is still controversial whether fasting blood glucose (FBG) is associated with the risk of vascular outcomes among nondiabetic subjects. We sought to determine whether FBG is associated with vascular outcomes and whether this association differs among various racial or ethnic groups. In the Northern Manhattan Study, a total of 2,372 subjects (mean age 68.8 +/- 10.7 years, 36% men) without a history of diabetes mellitus, stroke, or myocardial infarction (MI) were followed for an average of 7.5 years for ischemic stroke, MI, and combined vascular events defined as either ischemic stroke, MI, or vascular death. Cox proportional-hazards models were used to calculate hazard ratios and 95% confidence intervals (CIs) of FBG-associated risk for vascular outcomes after adjusting for age, gender, race/ethnicity, education, body mass index, hypertension, current smoking, previous coronary artery disease, low-density lipoprotein cholesterol, alcohol intake, and physical activity. The incidences of MI, ischemic stroke, and combined vascular events were 5.5, 6.3, and 20.0 per 1,000 person-years, respectively. Each SD increase of FBG (27 mg/dl) was associated with statistically significantly increased risks of combined vascular events (hazard ratio 1.20, 95% CI 1.09 to 1.31) and MI (hazard ratio 1.21, 95% CI 1.02 to 1.44), but the effect was weaker, evident for ischemic stroke (hazard ratio 1.13, 95% CI 0.95 to 1.34). FBG was significantly associated with incident ischemic stroke among African-American subjects (hazard ratio 1.38, 95% CI 1.09 to 1.74) and incident MI among Hispanic subjects (hazard ratio 1.24, 95% CI 0.99 to 1.55). In conclusion, FBG was an independent predictor for vascular outcomes among individuals without history of diabetes from this multiethnic cohort. The effects were more apparent for MI than for ischemic stroke; however, FBG was a strong predictor of ischemic stroke among African-American subjects.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17950798     DOI: 10.1016/j.amjcard.2007.06.032

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  4 in total

1.  Duration of diabetes and risk of ischemic stroke: the Northern Manhattan Study.

Authors:  Chirantan Banerjee; Yeseon P Moon; Myunghee C Paik; Tatjana Rundek; Consuelo Mora-McLaughlin; Julio R Vieira; Ralph L Sacco; Mitchell S V Elkind
Journal:  Stroke       Date:  2012-03-01       Impact factor: 7.914

Review 2.  Effect of pre-diabetes on future risk of stroke: meta-analysis.

Authors:  Meng Lee; Jeffrey L Saver; Keun-Sik Hong; Sarah Song; Kuo-Hsuan Chang; Bruce Ovbiagele
Journal:  BMJ       Date:  2012-06-07

3.  Management of Elevated Cholesterol in the primary prevention Group of Adult Japanese (MEGA) Study assists the view that a fasting plasma glucose level ≥100 mg/dL increases cardiovascular risk.

Authors:  Naoko Tajima; Hideaki Kurata; Yasuo Ohashi; Kyoichi Mizuno; Haruo Nakamura
Journal:  J Diabetes Investig       Date:  2011-10-07       Impact factor: 4.232

4.  Predictive Mortality Index for Community-Dwelling Elderly Koreans.

Authors:  Nan H Kim; Hyun J Cho; Soriul Kim; Ji H Seo; Hyun J Lee; Ji H Yu; Hye S Chung; Hye J Yoo; Ji A Seo; Sin Gon Kim; Sei Hyun Baik; Dong Seop Choi; Chol Shin; Kyung Mook Choi
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.